Abstract:The capacities of different transforming growth factor-beta (TGF-beta) superfamily members to drive epithelial to mesenchymal transdifferentiation of the murine mammary epithelial cell line NMuMG were investigated, TGF-beta 1 but not activin A or osteogenic protein-1 (OP-1)/bone morphogenetic protein-7 (BMP-7), was able to induce morphological transformation of NMuMG cells as shown by reorganisation of the actin cytoskeleton and relocalisation/downregulation of E-cadherin and beta-catenin, an effect that was abrogated by the more general serine/threonine kinase and protein kinase C inhibitor, staurosporine. TGF-beta 1 bound to TGF-beta type I receptor (T beta R-I)/ALK-5 and T beta R-II, but not to activin type I receptor (ActR-I)/ALK-2, Activin A bound to ActR-IB/ALK4 and ActR-II, and BMP-7 bound to ActR-I/ALK-2, BMP type I receptor (BMPR-I)/ALK-3, ActR-II and BMPR-II, TGF-beta 1 and BMP-7 activated the Smad-binding element (SBE)(4) promoter with equal potency, whereas activin A had no effect, Transfection of constitutively active (CA)-ALK-4 activated the 3TP promoter to the same extent as TGF-beta 1 and CA-ALK-5 indicating that activin signalling downstream of type I receptors was functional in NMuMG cells, In agreement with this, activin A induced low levels of plasminogen activator inhibitor I expression compared to the high induction by TGF-beta 1, In contrast to activin A and BMP-7, TGF-beta 1 strongly induced Smad2 phosphorylation, Consistent with these findings, TGF-beta 1 induced the nuclear accumulation of Smad2 and/or Smad3, In addition, NMuMG cells transiently infected with adenoviral vectors expressing high level CA-ALK-5 exhibited full transdifferentiation. On the other hand, infections with low level CA-ALK-5, which alone did not result in transdifferentiation, together with Smad2 and Smad4, or with Smad3 and Smad4 led to transdifferentiation. In conclusion, TGF-beta 1 signals potently and passes the activation threshold to evoke NMuMG cell transdifferentiation. The TGF-beta type I receptor (ALK-5) and its effector Smad proteins mediate the epithelial to mesenchymal transition, Activin A does not induce mesenchymal transformation, presumably because the number of activin receptors is limited, while BMP-7-initiated signalling cannot mediate transdifferentiation.

Metabolic Reprogramming of Mammary Epithelial Cells during TGF--Induced Epithelial-to-Mesenchymal Transition

TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.

Altered N-Glycan Expression Profile in Epithelial-to-mesenchymal Transition of NMuMG Cells Revealed by an Integrated Strategy Using Mass Spectrometry and Glycogene and Lectin Microarray Analysis.

Visualizing Dynamic Changes During TGF-β-Induced Epithelial to Mesenchymal Transition.

TGF‑β1‑induced epithelial‑mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p‑AMPK pathway in breast cancer cells.

Transforming Growth Factor-Β1 Induced Epithelial-Mesenchymal Transition in Hepatic Fibrosis.

TGF-β-dependent reprogramming of amino acid metabolism induces epithelial–mesenchymal transition in non-small cell lung cancers

TGFβ Selects for Pro‐stemness over Pro‐invasive Phenotypes During Cancer Cell Epithelial–mesenchymal Transition

TGF-β Type I Receptor/alk-5 and Smad Proteins Mediate Epithelial to Mesenchymal Transdifferentiation in NMuMG Breast Epithelial Cells

Mechanotactic Activation of TGF‐β by PEDOT Artificial Microenvironments Triggers Epithelial to Mesenchymal Transition

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

Alteration of mitochondrial synthesis and function in epithelial-mesenchymal transition by TGF-β1

Conditioned Medium from Malignant Breast Cancer Cells Induces an EMT-Like Phenotype and an Altered N-Glycan Profile in Normal Epithelial MCF10A Cells.

Epithelial-mesenchymal Transition of Type Ⅱ Alveolar Epithelial Cells Induced by TGF-β1

Downregulation of gangliotetraosylceramide and β1,3-galactosyltransferase-4 gene expression by Smads during transforming growth factor β-induced epithelial-mesenchymal transition.

Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT)

The Effect of TGF-beta-induced Epithelial–mesenchymal Transition on the Expression of Intracellular Calcium-Handling Proteins in T47D and MCF-7 Human Breast Cancer Cells

Phosphoproteomic Study of Human Tubular Epithelial Cell in Response to Transforming Growth Factor-Beta-1-induced Epithelial-to-mesenchymal Transition.

Extracellular matrix proteins regulate epithelial–mesenchymal transition in mammary epithelial cells

Transforming Growth Factor-Β1 Regulates Epithelial-Mesenchymal Transition in Association with Cancer Stem-Like Cells in a Breast Cancer Cell Line.